A Patient With Metastatic Sarcoma was Successfully Treated With Radiolabeled Somatostatin Analogs

ABSTRACTWe present a sarcoma patient with a tumor reduction of more than 50% in lung metastasis after 2 single courses of the investigational medical product Lutathera (Lu-DOTA0-Tyr3-octreotate). She was resistant to more than 6 lines of therapy including all the available active drugs in soft tissu...

Full description

Saved in:
Bibliographic Details
Published in:Clinical nuclear medicine Vol. 41; no. 9; pp. 705 - 707
Main Authors: Crespo-Jara, Aurora, González Manzano, Ramón, Lopera Sierra, Maribel, Redal Peña, María Carmen, Brugarolas Masllorens, Antonio
Format: Journal Article
Language:English
Published: United States Copyright Wolters Kluwer Health, Inc. All rights reserved 01-09-2016
Lippincott Williams & Wilkins
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACTWe present a sarcoma patient with a tumor reduction of more than 50% in lung metastasis after 2 single courses of the investigational medical product Lutathera (Lu-DOTA0-Tyr3-octreotate). She was resistant to more than 6 lines of therapy including all the available active drugs in soft tissue sarcomas. The high expression of somatostatin receptors was shown by microarrays and Octreoscan. The overall duration of response exceeded 1 year.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0363-9762
1536-0229
DOI:10.1097/RLU.0000000000001288